DOACs and Warfarin Flashcards
what does apixaban inhibit
direct inhibitor of FXa
mechanism of action of Apixaban
potent oral reversible direct and selective active site inhibitor of FXa
inhibits free and clot bound FXa and prothrombinase activity
what effect does Apixaban have on platelet aggregation
has no direct effect - indirectly inhibits aggregation induced by thrombin
prevents thrombin generation and thrombus development
dosing of Apixaban
10mg BD for 7 days
then 5mg BD for duration of treatment
when is dose reduction available for Apixaban
two of the following:
- > 80
- <60kg
- creatinine >133
true or false: dabigatran is a prodrug
true - it is a prodrug with no activity
mechanism of action of Dabigatran
competitive reversible direct thrombin inhibitor
following oral administration, dabigatran etexilate is rapidly absorbed and converted to active dabigatran by esterase catalysed hydrolysis in the liver and plasma
what does thrombin enable the conversion of
fibrinogen to fibrin during the coagulation cascade
therefore thrombin inhibition prevents the development of a thrombus
dosing of dabigatran
150mg BD following 5 days of parenteral therapy
when is dose reduction available on dabigatran
available to 110mg BD for those >80 years or also on verapamil
edoxaban mode of action
direct inhibitor of FXa
inhibits free FXa and prothrombinase activity
prevents thrombin generation and thrombus development
dosing of edoxaban
60mg OD following 5 days of parenteral therapy
when is dose reduction available on Edoxaban
dose reduction available to 30 mg OD when 1 or more of these are true:
- renal function between 15 and 50 ml/min
- <60kg
- use of certain medications such as erythromycin and cetoconazol
mode of action of rivaroxaban
direct inhibitor of FXa
prevents thrombus development in the same way as apixaban and edoxaban
dosing of rivaroxaban
15mg BD for 3 weeks then 20mg OD